Evaluation of the Zynex Blood Volume Monitor in Healthy Adult Patients During a Blood Draw

Zynex Monitoring Solutions

Status: Completed

Conditions: Blood Loss

Treatments: Device: CM 1500

Study type: Interventional

Funder types: Industry; Other

Identifiers

NCT01846195

Zynex500

Details and patient eligibility

About

Non-invasive monitoring to measure changes in blood volume.

Enrollment: 50 patients

Sex: All

Ages: 18 to 35 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy volunteers
• Between 18-35 years of age
• Weight between 130-200 pounds

Exclusion criteria

• Known cardiac disease
• Recent caffeine intake
• Tobacco use in the (4) hours prior to screening
• Infection
• Pregnancy
• Hemoglobin <13.5 g/dl

Trial design

Primary purpose: Other

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

50 participants in 2 patient groups

no blood draw

Sham Comparator group

Description:

CM 1500 with no blood draw

Treatment:

Device: CM 1500

blood draw

Active Comparator group

Description:

CM 1500 with blood draw

Treatment:

Device: CM 1500